Epilepsy Society, UCL And Congenica Join Forces In Genomic Study To Identify Causes Of SUDEP Sudden unexpected death in epilepsy (SUDEP) occurs in approximately 1/1000 people with epilepsy and is poorly understood Genomic studies will seek to identify underlying genetic causes, to improve clinical understanding Cambridge, United Kingdom – Congenica, the global diagnostic decision support […]

Quanterix’ technology to be used in multiplex diagnostic test for cervical disease detection LEXINGTON, Mass.– Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration agreement with OncoGenesis, a molecular protein-based cervical screening company, to develop a quantitative, protein biomarker diagnostic test for cervical health using […]

Amazon Web Services (AWS) has joined the National Institutes of Health’s Science and Technology Research Infrastructure for Discovery, Experimentation, and Sustainability (STRIDES) Initiative. Launched in July 2018, the STRIDES Initiative aims to harness the power of commercial cloud computing for NIH biomedical researchers. Initially, NIH’s efforts will focus on making high-value data sets more accessible to […]

Revealing the complete genome makeup of multiple varieties resolves the genetic basis of key traits Ness Ziona, Israel, and Salinas, Calif. – Kayagene, an innovative cannabis breeding company, and NRGene, the leading agricultural genomics company, are collaborating on research to enhance Kayagene’s breeding capabilities  to develop improved cannabis varieties and more robust seed production. The non-exclusive partnership between NRGene and Kayagene will […]

Frankfurt a.M. / Hainburg, Germany – The Fraunhofer Institute for Molecular Biology and Applied Ecology IME together with the Goethe University Frankfurt/Main and Pharma Test has developed the new Dispersion Releaser apparatus (PT-DR) for a standard dissolution tester to provide a solid system for the release testing of nanomedicines, microformulations and semi-solid dosage forms. Nanomedicine is on […]

New cutting-edge tools and services to fuel genomic discovery in humans, plants, animals and microbiome research now available in South Korea, Japan, China, Singapore, Malaysia, Indonesia, New Zealand and Australia Phase Genomics Hi-C Kits fuel genomic discovery in humans, plants, animals and microbiome research Easy-to-use Hi-C kits. Protocol takes approximately one day. Yields dual-indexed Illumina-compatible […]

Cambridge, UK – Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce that Cancer Research UK Manchester Institute (CRUK MI), has licensed Flare for fresh insights into structure-based drug design. “Putting easy-to use and visually driven structure-based design software in the hands of our medicinal chemists will empower them to deliver the next generation […]

Heidelberg and Dortmund, Germany – The National Center for Tumor Diseases (NCT) Heidelberg and Protagen AG today announced a collaboration to utilize Protagen’s Cancer Immunotherapy Array to identify biomarkers that predict therapeutic response and the incidence of immune-related adverse events (irAEs) in urothelial carcinoma patients treated with checkpoint inhibitors. In recent years, checkpoint inhibitors have […]

Effort Designed to Safely and Efficiently Speed Drug Candidates into the Clinic Geneva, Switzerland – Selexis SA and Berkeley Lights, Inc. today announced a collaboration around the acquisition of Berkeley Lights’ Beacon® optofluidic platform. The partners will leverage the technology to accelerate cell line development (CLD) with the Selexis SUREtechnology Platform™. Selexis scientists have extensively evaluated the Beacon […]